Anthracycline-induced cardiotoxicity and renin-angiotensin-aldosterone system—from molecular mechanisms to therapeutic applications
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Anthracycline-induced cardiotoxicity and renin-angiotensin-aldosterone system—from molecular mechanisms to therapeutic applications ; day:30 ; month:5 ; year:2020 ; pages:1-25
Heart failure reviews ; (30.5.2020), 1-25
- Urheber
-
Sobczuk, Paweł
Czerwińska, Magdalena
Kleibert, Marcin
Cudnoch-Jędrzejewska, Agnieszka
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10741-020-09977-1
- URN
-
urn:nbn:de:101:1-2020080219054180353036
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sobczuk, Paweł
- Czerwińska, Magdalena
- Kleibert, Marcin
- Cudnoch-Jędrzejewska, Agnieszka
- SpringerLink (Online service)
Ähnliche Objekte (12)
The renin angiotensin aldosterone system
Symposium Renin-Angiotensin-Aldosterone System and Hypertension
Renin–Angiotensin–Aldosterone Inhibitors and COVID-19 Infection
Anthracycline Chemotherapy and Cardiotoxicity
Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
Independent regulation of renin–angiotensin–aldosterone system in the kidney
Renin angiotensin aldosterone system blockade in practice: A Clinical Perspective
Metabolic Aspects of Anthracycline Cardiotoxicity
Cardioprotection strategies for anthracycline cardiotoxicity
Concomitant use of renin-angiotensin-aldosterone system inhibitors prevent trastuzumab-induced cardiotoxicity in HER2+ breast cancer patients: an institutional retrospective study
The renin–angiotensin–aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II
Cross-talk between exercises and renin-angiotensin-aldosterone-system blockade in hypertension
The renin angiotensin aldosterone system
Symposium Renin-Angiotensin-Aldosterone System and Hypertension
Renin–Angiotensin–Aldosterone Inhibitors and COVID-19 Infection
Anthracycline Chemotherapy and Cardiotoxicity
Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
Independent regulation of renin–angiotensin–aldosterone system in the kidney
Renin angiotensin aldosterone system blockade in practice: A Clinical Perspective
Metabolic Aspects of Anthracycline Cardiotoxicity
Cardioprotection strategies for anthracycline cardiotoxicity
Concomitant use of renin-angiotensin-aldosterone system inhibitors prevent trastuzumab-induced cardiotoxicity in HER2+ breast cancer patients: an institutional retrospective study
The renin–angiotensin–aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II
Cross-talk between exercises and renin-angiotensin-aldosterone-system blockade in hypertension
The renin angiotensin aldosterone system
Symposium Renin-Angiotensin-Aldosterone System and Hypertension
Renin–Angiotensin–Aldosterone Inhibitors and COVID-19 Infection
Anthracycline Chemotherapy and Cardiotoxicity
Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
Independent regulation of renin–angiotensin–aldosterone system in the kidney
Renin angiotensin aldosterone system blockade in practice: A Clinical Perspective
Metabolic Aspects of Anthracycline Cardiotoxicity
Cardioprotection strategies for anthracycline cardiotoxicity
Concomitant use of renin-angiotensin-aldosterone system inhibitors prevent trastuzumab-induced cardiotoxicity in HER2+ breast cancer patients: an institutional retrospective study
The renin–angiotensin–aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II